Postmenopausal osteoporosis can be classified as an inflammatory, or even an autoimmune condition, hence new therapeutic immune targets. Some recently published works in this area are summarized, which may help to find a noval strategy for the treatment and prevention of postmenopausal osteoporosis.
Key words:
Osteoporosis, postmenopausal; Osteoimmunology ; Osteoblasts; Osteoclasts; Immune competent cells